Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.75
0.00 (0.00%)
Jun 26, 2026, 3:26 PM GMT
Poolbeg Pharma Employees
Poolbeg Pharma had 15 employees as of December 31, 2025. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-379.67K GBP
Market Cap
47.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15 | -1 | -6.25% |
| Dec 31, 2024 | 16 | 1 | 6.67% |
| Dec 31, 2023 | 15 | 3 | 25.00% |
| Dec 31, 2022 | 12 | 5 | 71.43% |
| Dec 31, 2021 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| hVIVO | 376 |
| Hemogenyx Pharmaceuticals | 16 |
| Sareum Holdings | 5 |
| SkinBioTherapeutics | 41 |
| 4basebio | 140 |
| Bioventix | 12 |
| ImmuPharma | 7 |
| Faron Pharmaceuticals Oy | 33 |
Poolbeg Pharma News
- 14 days ago - London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ - The Guardian
- 16 days ago - Poolbeg Pharma Slides: Corporate presentation - Filings
- 20 days ago - SMALL CAP IDEA: Poolbeg Pharma and the oral drug that could unlock cancer immunotherapy's biggest problem - This is Money
- 2 months ago - Poolbeg Pharma Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Poolbeg Pharma Annual report: H2 2025 - Filings
- 2 months ago - Poolbeg Pharma Slides: H2 2025 - Filings
- 2 months ago - Poolbeg Pharma Annual report: H2 2025 - Filings
- 9 months ago - Poolbeg Pharma Transcript: Study Update - Transcripts